https://www.selleckchem.com/pr....oducts/Mubritinib-TA
to describe the factors related to psychological impairment and quality of life (QoL) of patients with schizophrenia. a cross-sectional, descriptive and correlational study, carried out with 119 schizophrenics. A questionnaire of sociodemographic and clinical variables was applied, plus BPRS-A and QLS-BR scales. Chi-square test and Spearman's correlation were used. seventy-seven were male and 44 were using typical medications. The "Number of times they were hospitalized" related to "Time of illness" that patients live with sc
Like
Comment
Share
